首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   17754篇
  免费   1242篇
  国内免费   32篇
耳鼻咽喉   277篇
儿科学   498篇
妇产科学   593篇
基础医学   2147篇
口腔科学   260篇
临床医学   2518篇
内科学   3080篇
皮肤病学   323篇
神经病学   1478篇
特种医学   689篇
外国民族医学   1篇
外科学   1734篇
综合类   202篇
一般理论   27篇
预防医学   2510篇
眼科学   179篇
药学   1138篇
中国医学   10篇
肿瘤学   1364篇
  2023年   85篇
  2022年   137篇
  2021年   307篇
  2020年   226篇
  2019年   349篇
  2018年   409篇
  2017年   307篇
  2016年   322篇
  2015年   344篇
  2014年   505篇
  2013年   724篇
  2012年   1106篇
  2011年   1028篇
  2010年   579篇
  2009年   568篇
  2008年   1005篇
  2007年   1067篇
  2006年   1038篇
  2005年   1059篇
  2004年   967篇
  2003年   968篇
  2002年   893篇
  2001年   308篇
  2000年   249篇
  1999年   291篇
  1998年   207篇
  1997年   180篇
  1996年   184篇
  1995年   137篇
  1994年   135篇
  1993年   122篇
  1992年   197篇
  1991年   210篇
  1990年   195篇
  1989年   209篇
  1988年   167篇
  1987年   155篇
  1986年   149篇
  1985年   158篇
  1984年   157篇
  1983年   128篇
  1982年   124篇
  1981年   96篇
  1980年   97篇
  1979年   126篇
  1978年   106篇
  1975年   80篇
  1974年   92篇
  1973年   85篇
  1971年   78篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
ObjectivesCocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (CUD)-related deaths increased globally by 80% from 1990 to 2013. There is yet to be a regulatory-approved treatment. Emerging preclinical evidence indicates that deep brain stimulation (DBS) of the nucleus accumbens may be a therapeutic option. Prior to expanding the costly investigation of DBS for treatment of CUD, it is important to ensure societal cost-effectiveness.AimsWe conducted a threshold and cost-effectiveness analysis to determine the success rate at which DBS would be equivalent to contingency management (CM), recently identified as the most efficacious therapy for treatments of CUDs.Materials and MethodsQuality of life, efficacy, and safety parameters for CM were obtained from previous literature. Costs were calculated from a societal perspective. Our model predicted the utility benefit based on quality-adjusted life-years (QALYs) and incremental-cost-effectiveness ratio resulting from two treatments on a one-, two-, and five-year timeline.ResultsOn a one-year timeline, DBS would need to impart a success rate (ie, cocaine free) of 70% for it to yield the same utility benefit (0.492 QALYs per year) as CM. At no success rate would DBS be more cost-effective (incremental-cost-effectiveness ratio <$50,000) than CM during the first year. Nevertheless, as DBS costs are front loaded, DBS would need to achieve success rates of 74% and 51% for its cost-effectiveness to exceed that of CM over a two- and five-year period, respectively.ConclusionsWe find DBS would not be cost-effective in the short term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy.  相似文献   
5.
6.
7.
This paper reports an inter-rater reliability study on the Functional Independence Measure (FIM). The FIM measures inpatient burden of care, as reflected in 18 self care items, rated on a seven point scale from dependent to independent. The subjects were 40 occupational therapists, divided according to experience with the FIM and randomly assigned to a FIM training or non-training group. Subjects rated video tapes of four stroke patients on transfers, bathing, dressing, grooming, toileting and eating items from the FIM. Rater consensus was calculated using the intraclass correlation coefficient (ICC), percentage agreement and a measure of disagreement. Rating accuracy was measured by comparisons with an expert rater. Ratings were most reliable when done by clinicians with no prior FIM experience, from the FIM training group. It is strongly recommended that all clinicians undergo FIM training before using this tool to ensure acceptable reliability.  相似文献   
8.
9.
Forty-one multiplex families, from published sources and new data from the National Cancer Institute, segregating for Hodgkin's disease and HLA, have been studied. A reanalysis of these data strongly suggests a recessive mode of inheritance for susceptibility to Hodgkin's disease. The HLA haplotype sharing data between affected relatives demonstrate that approximately 60% of cases in multiplex families are due to an HLA-linked susceptibility gene, the remaining 40% being due to other familial factors. The data clearly support the hypothesis of etiological heterogeneity for Hodgkin's disease, with both HLA-linked and HLA-unlinked factors being responsible. Finally, there is an increased concordance of histological types between affected relatives, but this concordance seems independent of HLA sharing.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号